Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,399,329 papers from all fields of science
Search
Sign In
Create Free Account
ES06 (cell line)
Known as:
ES06
, HES-6
Provider: ES Cell International Pte Ltd., Melbourne, Australia. Information from provider and not independently verified by NIH: Undergoing…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Abstract ES06-2: The impact of biological age
A. Ring
2013
Corpus ID: 72691471
The prognosis of a woman with early breast cancer is dependent on both tumor and patient characteristics. Tumor-related…
Expand
2013
2013
Abstract ES06-1: Adjuvant chemotherapy in the elderly: Making the right decision
H. Muss
2013
Corpus ID: 72249508
The major risk factor for breast cancer is increasing age and we all need to get ready to care for the tsunami of older breast…
Expand
2009
2009
ES06 *A STUDY OF NORCHOLESTEROL SCINTIGRAPHY VERSUS COMPUTED TOMOGRAPHY IN THE LATERALISATION OF HYPERFUNCTIONING ADRENAL LESIONS
E. Şanlı
,
C. Tan
,
S. Sidhu
,
M. Sywak
2009
Corpus ID: 53789714
Purpose: Norcholesterol adrenal scintigraphy (Norchol) and computed tomography (CT) are frequently utilised in the…
Expand
2008
2008
ANTIPROLIFERATIVE ACTION OF ESTROGEN RECEPTOR β AND HES-1 IN BREAST CANCER
J. Hartman
,
I. A. Ström
,
+4 authors
J. Inzunza
2008
Corpus ID: 53685324
Breast cancer is the most common malignancy among Swedish women. Although the mechanism behind the tumorigenesis remains unclear…
Expand
Review
2007
Review
2007
ES06 ADRENALECTOMY IN THE LAPAROSCOPIC ERA
J. Boldery
,
I. Gough
2007
Corpus ID: 73125771
Background Laparoscopic adrenalectomy is now the accepted standard of care in surgical treatment of most forms of adrenal…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE